Nicolau Moreira Abrahão

Nicolau Moreira Abrahão

Auto-generated profile, based on publicly available information

Nicolau Moreira Abrahão

Universidade Estadual de Campinas (UNICAMP), Department of Otolaryngology, Campinas, SP, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2023 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
VSVagner Antonio Rodrigues da Silva
Vagner Antonio Rodrigues da Silva
HPHenrique Furlan Pauna
Henrique Furlan Pauna
JLJoel Lavinsky
Joel Lavinsky
GGGuilherme Correa Guimaraes
Guilherme Correa Guimaraes
NANicolau Moreira Abrahão
Nicolau Moreira Abrahão
ACArthur Menino Castilho
Arthur Menino Castilho
To review and provide evidence-based recommendations for the diagnosis and treatment of otosclerosis. Task force members were educated on knowledge synthesis methods, including electronic database search, review and selection of relevant citations, and critical appraisal of selected studies. Articles written in English or Portuguese on otosclerosis were eligible for inclusion. The American College of Physicians' guideline grading system and the American Thyroid Association's guideline criteria were used for critical appraisal of evidence and recommendations for therapeutic interventions. The topics were divided into 2 parts: 1) Diagnosis - audiologic and radiologic; 2) Treatment - hearing AIDS, pharmacological therapy, stapes surgery, and implantable devices - bone-anchored devices, active middle ear implants, and Cochlear Implants (CI). The pathophysiology of otosclerosis has not yet been fully elucidated, but environmental factors and unidentified genes are likely to play a significant role in it. Women with otosclerosis are not at increased risk of worsening clinical condition due to the use of contraceptives or during pregnancy. Drug treatment has shown little benefit. If the patient does not want to undergo stapedotomy, the use of hearing aids is well indicated. Implantable systems should be indicated only in rare cases, and the CI should be indicated in cases of profound deafness.

8 December 2023 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
HPHenrique Furlan Pauna
Henrique Furlan Pauna
VSVagner Antonio Rodrigues da Silva
Vagner Antonio Rodrigues da Silva
JLJoel Lavinsky
Joel Lavinsky
MHMiguel Hyppolito
Miguel Hyppolito
MVMelissa Ferreira Vianna
Melissa Ferreira Vianna
ACArthur Menino Castilho
Arthur Menino Castilho
To review key evidence-based recommendations for the diagnosis and treatment of peripheral facial palsy in children and adults. Task force members were educated on knowledge synthesis methods, including electronic database search, review and selection of relevant citations, and critical appraisal of selected studies. Articles written in English or Portuguese on peripheral facial palsy were eligible for inclusion. The American College of Physicians' guideline grading system and the American Thyroid Association's guideline criteria were used for critical appraisal of evidence and recommendations for therapeutic interventions. The topics were divided into 2 main parts: (1) Evaluation and diagnosis of facial palsy: electrophysiologic tests, idiopathic facial palsy, Ramsay Hunt syndrome, traumatic peripheral facial palsy, recurrent peripheral facial palsy, facial nerve tumors, and peripheral facial palsy in children; and (2) Rehabilitation procedures: surgical decompression of the facial nerve, facial nerve grafting, surgical treatment of long-term peripheral facial palsy, and non-surgical rehabilitation of the facial nerve. Peripheral facial palsy is a condition of diverse etiology. Treatment should be individualized according to the cause of facial nerve dysfunction, but the literature presents better evidence-based recommendations for systemic corticosteroid therapy.

22 June 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
NANicolau Moreira Abrahão
Nicolau Moreira Abrahão
GGGuilherme Correa Guimaraes
Guilherme Correa Guimaraes
ACArthur Menino Castilho
Arthur Menino Castilho
VSVagner Antonio Rodrigues da Silva
Vagner Antonio Rodrigues da Silva
When temporal bone fractures are associated with facial palsy (FP) evolution the medical team have no much time to make a decision: to do or not to do a surgical approach? How to evaluate the necessity? When to do it and when is the correct time?

8 April 2024 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
NANicolau Moreira Abrahão
Nicolau Moreira Abrahão
GGGuilherme Correa Guimaraes
Guilherme Correa Guimaraes
JTJonas Belchior Tamanini
Jonas Belchior Tamanini
SCSofia Fontes de Oliva Costa
Sofia Fontes de Oliva Costa
PFPedro Juliano de Mesquita Ferreira
Pedro Juliano de Mesquita Ferreira
ACArthur Menino Castilho
Arthur Menino Castilho

23 July 2026 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
NANicolau Moreira Abrahão
Nicolau Moreira Abrahão
ACArthur Menino Castilho
Arthur Menino Castilho
EMEduardo Tanaka Massuda
Eduardo Tanaka Massuda
VSVagner Antonio Rodrigues da Silva
Vagner Antonio Rodrigues da Silva
This study aims to evaluate the importance of universal screening for congenital Cytomegalovirus (CMV) infection in newborns using urine PCR to identify asymptomatic cases at birth, with or without early hearing impairment, and to monitor this population for the development of late-onset hearing loss. This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The literature search was conducted through four online databases ‒ PUBMED, PUBMED PMC, BVS/BIREME, and EMBASE ‒ for papers published until January 2025. The Newcastle-Ottawa Scale was used to assess the risk of bias. The search strategy identified 824 articles. Following the abstract screening, 22 studies were selected for full-text review, of which three met the criteria for data synthesis. All three studies were prospective, applied universal CMV screening through urine PCR, and followed patients with auditory brainstem response for at least four years. A meta-analysis was performed using a random-effects model with inverse-variance weighting and the Restricted Maximum Likelihood estimator. Among the three studies included in the assessment, 56,892 newborns were screened with urine samples. The meta-analysis found a proportion of prevalence of congenital CMV infection of 0.46%. The proportions of asymptomatic cases and late hearing impairment was 83.4% and 13.9%, respectively. Additionally, early hearing impairment was detected in 22 (12%) newborns, and one study demonstrated that 11% of asymptomatic patients developed long-term neurological sequelae in addition to hearing loss. Our meta-analysis evaluated epidemiological aspects of hearing loss associated with cCMV infection and found that a significant proportion of infants with asymptomatic infection develop late-onset hearing loss. The absence of structured screening risks missing these patients in long-term follow-up and may increase costs related to delayed diagnosis and investigation. Level 2.